{"abstract":"The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval actions for new animal drug applications (NADAs) and abbreviated new animal drug applications (ANADAs) during May 2013. FDA is also informing the public of the availability of summaries the basis of approval and of environmental review documents, where applicable.","action":"Final rule.","agencies":[{"raw_name":"DEPARTMENT OF HEALTH AND HUMAN SERVICES","name":"Health and Human Services Department","id":221,"url":"https://www.federalregister.gov/agencies/health-and-human-services-department","json_url":"https://www.federalregister.gov/api/v1/agencies/221","parent_id":null,"slug":"health-and-human-services-department"},{"raw_name":"Food and Drug Administration","name":"Food and Drug Administration","id":199,"url":"https://www.federalregister.gov/agencies/food-and-drug-administration","json_url":"https://www.federalregister.gov/api/v1/agencies/199","parent_id":221,"slug":"food-and-drug-administration"}],"body_html_url":"https://www.federalregister.gov/documents/full_text/html/2013/07/15/2013-16258.html","cfr_references":[{"chapter":null,"citation_url":null,"part":520,"title":21},{"chapter":null,"citation_url":null,"part":558,"title":21}],"citation":"78 FR 42006","comment_url":null,"comments_close_on":null,"correction_of":null,"corrections":[],"dates":"This rule is effective July 15, 2013.","disposition_notes":null,"docket_ids":["Docket No. FDA-2013-N-0002"],"dockets":[],"document_number":"2013-16258","effective_on":"2013-07-15","end_page":42008,"executive_order_notes":null,"executive_order_number":null,"full_text_xml_url":"https://www.federalregister.gov/documents/full_text/xml/2013/07/15/2013-16258.xml","html_url":"https://www.federalregister.gov/documents/2013/07/15/2013-16258/oral-dosage-form-new-animal-drugs-nicarbazin-oclacitinib-zilpaterol","images":{},"images_metadata":{},"json_url":"https://www.federalregister.gov/api/v1/documents/2013-16258?publication_date=2013-07-15","mods_url":"https://www.govinfo.gov/metadata/granule/FR-2013-07-15/2013-16258/mods.xml","not_received_for_publication":null,"page_length":3,"page_views":{"count":1009,"last_updated":"2026-07-28 04:15:03 -0400"},"pdf_url":"https://www.govinfo.gov/content/pkg/FR-2013-07-15/pdf/2013-16258.pdf","presidential_document_number":null,"proclamation_number":null,"public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2013-16258.pdf?1373633353","publication_date":"2013-07-15","raw_text_url":"https://www.federalregister.gov/documents/full_text/text/2013/07/15/2013-16258.txt","regulation_id_number_info":{},"regulation_id_numbers":[],"regulations_dot_gov_info":{"checked_regulationsdotgov_at":"2013-08-04T06:00:15Z"},"regulations_dot_gov_url":null,"significant":null,"signing_date":null,"start_page":42006,"subtype":null,"title":"Oral Dosage Form New Animal Drugs; Nicarbazin; Oclacitinib; Zilpaterol","toc_doc":"Nicarbazin; Oclacitinib; Zilpaterol","toc_subject":"Oral Dosage Form New Animal Drugs:","topics":["Animal drugs"],"type":"Rule","volume":78}